Xumin Wang

发表

A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study.

G. Watts, J. Pang, C. Stefanutti, 2019, Journal of clinical lipidology.

A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patients

Y. Hao, Jie Lin, Juan Du, 2022, Atherosclerosis plus.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Familial hypercholesterolemia in China half a century: A review of published literature.

Jing Hong, Jie Lin, Xue Wu, 2019, Atherosclerosis. Supplements.

A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family.

Shu Liu, Zhi-Sheng Jiang, Luya Wang, 2010, Chinese medical journal.

PCSK9 Inhibitor Induces a Transient Decrease in Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio in Homozygous/Compound Heterozygous Familial Hypercholesterolemia Patients

Y. Hao, Jie Lin, Juan Du, 2021 .

Reverse cascade screening for familial hypercholesterolemia in high‐risk Chinese families

G. Watts, J. Pang, Jie Lin, 2017, Clinical cardiology.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.